التفاصيل البيبلوغرافية
| العنوان: |
Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar. |
| المؤلفون: |
Steinhoff, Martin, Adeli, Mehdi, Riad, Hassan, Allam, Mohamed, Hazem, Ahmad, Alsmadi, Ra'ed, Kamal, Adel Mohamed, Ibrahim, Waad, Al-Nesf, Maryam Ali |
| المصدر: |
Journal of Dermatological Treatment; 2023, Vol. 34 Issue 1, p1-11, 11p |
| مصطلحات موضوعية: |
ATOPIC dermatitis, ITCHING, MEDICAL personnel, SCABIES, DELPHI method, DUPILUMAB |
| مصطلحات جغرافية: |
QATAR |
| مستخلص: |
Atopic dermatitis (AD), a chronic-relapsing inflammatory skin disorder, manifests with intense itching and eczematous lesions impairing quality of life. A heterogeneous population, and regional clinical practices for treating AD warrant the development of guidelines in Qatar. Therefore, guidelines for the management of moderate-to-severe AD in Qatar have been developed and discussed. Experts, including dermatologists and immunologists, used the Delphi technique for developing guidelines. Consensus was defined as ≥75% agreement or disagreement. AD is highly prevalent in primary and tertiary dermatology centers. AD-associated foot eczema and psoriasiform eczema are more frequent in Qatar than in Europe or USA. SCORing Atopic Dermatitis Index quantifies disease severity and itch. Dermatology Life Quality Index assesses the quality of life. Atopic Dermatitis Control Tool assesses long-term disease control. Moderate-severe AD benefits from new topicals like Janus-kinase-inhibitors or PDE4-inhibitors combined with phototherapy. Currently approved systemic agents are dupilumab, baricitinib, abrocitinib, and upadacitinib. New anti-IL-13 and anti-IL-31 therapies will soon be available. Patient education, allergy testing, and comorbidity consideration are critical in the management of AD. The expert panel established a comprehensive and pragmatic approach to managing moderate-to-severe AD, thereby assisting clinical decision-making for healthcare professionals in Qatar. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Dermatological Treatment is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
